NBA: Bulls G Lonzo Ball to undergo knee surgery, doubtful for season’s start

Date:

Share post:


Chicago Bulls guard Lonzo Ball will undergo surgery next week on his problematic left knee.

The team said the procedure, an arthroscopic debridement of the knee, will be done Sept. 28 in Los Angeles.

He will be re-evaluated in four to six weeks.

Last season, Ball tore the meniscus in his left knee and last played Jan. 14. In late April, he told reporters that he was still experiencing pain.

The 24-year-old had arthroscopic surgery on his knee in January and the Bulls hoped he could return in six to eight weeks. Instead, he couldn’t get back to full basketball activities and was shut down before the end of the regular season.

In his first season in Chicago after two years with the Los Angeles Lakers and two with the New Orleans Pelicans, Ball averaged 13.0 points, 5.4 rebounds, 5.1 assists and 1.8 steals per game in 35 starts.

NBA training camps open Tuesday. The Bulls are scheduled to play their first preseason game on Oct. 4 against the Pelicans.

Given the Bulls’ timeline, Ball is unlikely for the season opener, Oct. 19 at the Miami Heat.

–Field Level Media

spot_img

Related articles

WNCAAB: Caitlin Clark becomes first 2-time Sullivan Award honoree

Caitlin Clark, who broke the NCAA women's basketball single-season and career scoring records in a stellar senior season...

WNBA: Epiphanny Prince joins Liberty’s front office on heels of retiring

Two-time All-Star guard Epiphanny Prince was hired as the New York Liberty's director of player and community engagement,...

WNBA: Reports: Caitlin Clark to sign 8-year, $28 million Nike deal

Caitlin Clark is far from done setting records. Her latest will come off the court. The Iowa star-turned-No. 1...

NCAAB: Ex-ballyhooed recruit Omaha Biliew transfers to Wake Forest

Former five-star recruit Omaha Biliew has transferred to Wake Forest after experiencing a disappointing freshman campaign at Iowa...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.